Yi Song

Yi Chi Song is an Associate at Casdin Capital, LLC, an investment firm headquartered in New York, NY, specializing in long-short equity and fundamental research within the life sciences and healthcare sectors. In his current role, Song contributes to the firm's research and investment decisions, primarily targeting biotechnology, therapeutics, clinical trials, and health diagnostics companies—a focus consistent with Casdin Capital's core strategy.

Song brings a strong background in equity research and consulting for biotech and life science companies, having previously served as a Biotech Equity Research Associate at Jefferies, where he analyzed public and private biotech firms, and as an Analyst at Back Bay Life Science Advisors, a consulting group specializing in strategy for life sciences sector clients.

He graduated summa cum laude with a Bachelor of Science in Biochemistry from Tufts University and holds an International Baccalaureate Diploma from Dulwich College Beijing. Song's expertise spans biotechnology, drug development, biopharmaceuticals, and healthcare market analysis, supporting Casdin Capital's reputation for deep sectoral research and investments in advanced therapeutics and diagnostics.